Target intelligence / Profile preview

Variable charge X-linked protein 2 (VCX2)

Target
VCX2
Molecular classification
Other (small nuclear protein of unknown function)[1][3][9]
01

Overview

Variable charge X-linked protein 2 (VCX2) is a small, highly charged nuclear protein encoded by a gene located in the VCX/Y gene family cluster on the human X chromosome (Xp22); the family has homologous genes on both X and Y chromosomes, typically expressed in male germ cells[1][2][4][8][9]. VCX2 contains tandem repeats of a 30-base pair sequence and exhibits a highly polymorphic copy number across individuals[1][4][8]. Its precise biological function remains uncharacterized, though gene ontology and protein studies speculate a role in spermatogenesis or in affecting sex ratio, based on expression patterns and family homology[3][9]. VCX2 is not recognized as a therapeutic target, lacks association with any approved drugs, and is not implicated as a biomarker or direct causative gene for major diseases, though gene family members have been linked to certain X-linked disorders[4][5][9].

Other names
VCX2VCX-2rVCX2RVCXBVCX-BVariable charge protein on X with two repeatsVariably charged protein X-BVariable charge X-linked protein 2Variably charged, X chromosome BVariably charged, X chromosome 2Variably charged, X chromosome with 2 repeats
02

Mechanism of action

Not established (due to the absence of therapeutic targeting and undefined function)[1][9]

03

Biological functions

UnknownPossible role in spermatogenesisPossible role in sex ratio distortion[9]
04

Disease associations

Other (Diseases associated with the VCX gene family, such as X-linked ichthyosis and Kallmann syndrome, but not specifically attributed to VCX2)[5]

Beyond the preview

Go deeper on Variable charge X-linked protein 2 (VCX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Variable charge X-linked protein 2 (VCX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call